Back to Viking Global Investors LP Viking Global Investors LP

NAMSNAMS

Showing 8 of 15 quarters

Position history for Viking Global Investors LPViking Global Investors LP's holdings in NewAmsterdam Pharma Company N.V.

Yes. Viking Global Investors holds 4,203,567 shares of NAMS (NewAmsterdam Pharma), worth $142.5M, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. Viking Global Investors has held NAMS since Q4 2022, across 15 quarterly 13F filings. NAMS is 0.4% of Viking Global Investors' reported 13F portfolio.

Current Value

$142.5M

Current Shares

4.2M

Total Value Change

+$9.3M

Total Shares Change

-3.8M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
4.2M
0.0%
$142.5M0.4%$33.89
0
2026-Q1
Unchanged
4.2M
0.0%
$134.6M0.4%$32.01
0
2025-Q4
Decreased
4.2M
-35.1%
$147.5M0.4%$35.08
0
2025-Q3
Decreased
6.5M
-7.2%
$184.2M0.5%$28.44
0
2025-Q2
Unchanged
7M
0.0%
$126.4M0.4%$18.11
0
2025-Q1
Unchanged
7M
0.0%
$142.9M0.5%$20.47
0
2024-Q4
Decreased
7M
-13.0%
$179.3M0.6%$25.70
0
2024-Q3
Unchanged
8M
0.0%
$133.2M0.5%$16.60
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used